Esperion Therapeutics
ESPR
#6990
Rank
C$0.61 B
Marketcap
$3.15
Share price
0.69%
Change (1 day)
1.66%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -C$38.66 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are C$0.29 Billion. In 2023 the company made an earning of -C$0.22 Billion, an increase over its 2022 earnings that were of -C$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$38.66 Million-82.1%
2023 -C$0.22 Billion-15.03%
2022 -C$0.26 Billion-20.61%
2021 -C$0.33 Billion84.28%
2020 -C$0.18 Billion35.75%
2019 -C$0.13 Billion-55.71%
2018 -C$0.29 Billion19.57%
2017 -C$0.25 Billion125.39%
2016 -C$0.11 Billion51.43%
2015 -C$70.79 Million36.45%
2014 -C$51.88 Million43.55%
2013 -C$36.14 Million145.26%
2012 -C$14.74 Million
2002 -C$42.01 Million-7.81%
2001 -C$45.57 Million15.03%
2000 -C$39.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.72 Billion 1,617.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.56 B-1,455.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.97 B-24,136.70%๐Ÿ‡บ๐Ÿ‡ธ USA
C$7.14 B-17,304.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$98.21 Million 136.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.32 Billion 649.15%๐Ÿ‡บ๐Ÿ‡ธ USA